Under the agreement Medtronic will act as the exclusive sales agent of MagnetOs for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries, according to a Jan. 7 news release. Kuros Biosciences, which is behind MagnetOs, will support Medtronic’s sales team and be responsible for contracts and partnerships.
MagnetOs bone grafts use NeedleGrip surface technology to aid bone growth in soft issues and a more predictable spinal fusion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
